# References for *C. auris* BRC-Analytics White Paper

## Primary Publications (Re-analyzed Studies)

1. **Santana et al. (2023)** - *Science*
   - Title: "A *Candida auris*-specific adhesin, Scf1, governs surface association, colonization, and virulence"
   - Journal: *Science*. 2023;381(6665):1461-1467
   - PubMed: https://pubmed.ncbi.nlm.nih.gov/37769084/
   - BioProject: PRJNA904261
   - Analysis location: `/home/anton/git/claude-projects/rnaseq/santana24_PRJNA904261/`

2. **Wang et al. (2024)** - *Nature Communications*
   - Title: "Cell surface glycan-lectin interactions modulate *Candida auris* colonization and fungemia"
   - Journal: *Nat Commun*. 2024;15:6490
   - DOI: https://doi.org/10.1038/s41467-024-50434-4
   - PubMed: https://pubmed.ncbi.nlm.nih.gov/38562758/
   - BioProject: PRJNA1086003
   - Analysis location: `/home/anton/git/claude-projects/rnaseq/wang24_PRJNA1086003/`

## First Description of *C. auris*

3. **Satoh et al. (2009)** - First isolation
   - Title: "*Candida auris* sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital"
   - Journal: *Microbiol Immunol*. 2009;53(1):41-44
   - PubMed: https://pubmed.ncbi.nlm.nih.gov/19161556/
   - Significance: First documented case and taxonomic description

## Public Health Authority Resources

4. **CDC - *Candida auris* Resources**
   - Urgent threat designation: https://www.cdc.gov/media/releases/2023/p0320-cauris.html (March 2023)
   - Clinical overview: https://pmc.ncbi.nlm.nih.gov/articles/PMC11946832/
   - PDF fact sheet: https://www.cdc.gov/antimicrobial-resistance/media/pdfs/candida-auris-508.pdf
   - Key facts: First fungal pathogen designated as "urgent" AR threat; cases doubled annually; 30-60% mortality

5. **NIAID - Fungal Pathogen Priority**
   - Main page: https://www.niaid.nih.gov/news-events/candida-auris-mysterious-and-tenacious-enemy
   - 2025 funding priorities: https://amr.solutions/2024/11/26/niaid-dmid-call-for-antibacterials-antifungals-vaccines-diagnostics/
   - BAA announcement: HHS-NIH-NIAID-BAA2025-1 (seeking therapeutics, diagnostics, vaccines)

6. **WHO - Critical Priority Fungal Pathogen**
   - Systematic review: https://pubmed.ncbi.nlm.nih.gov/38935900/
   - Full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC11210622/
   - Designation: WHO critical-priority fungal pathogen

## Intergalactic Workflow Commission (IWC)

7. **IWC - Galaxy Workflows**
   - Main website: https://iwc.galaxyproject.org/
   - GitHub repository: https://github.com/galaxyproject/iwc
   - WorkflowHub: https://workflowhub.eu/projects/33
   - Description: Community-maintained, tested, versioned Galaxy workflows automatically installed on usegalaxy.* servers

## RNA-seq Best Practices and Validation

8. **Zenodo - RNA-seq Analysis Best Practices**
   - DOI: https://zenodo.org/records/3985047
   - Content: Strategies for validating and interpreting RNA-seq data

9. **PMC - Global Threat Review**
   - Title: "Act Now: The Global Threat of Candida Auris and the Urgent Need for Effective Countermeasures"
   - URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11221456/
   - Content: Comprehensive review of *C. auris* threat and research priorities

## NCBI Resources

10. **NCBI Taxonomy Browser**
    - *Candidozyma auris* (txid498019): https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=498019
    - NCBI Datasets: https://www.ncbi.nlm.nih.gov/datasets/taxonomy/498019/

11. **Reference Genome - GCA_002759435.3**
    - Assembly: *Candidozyma auris* B8441 V3
    - URL: https://www.ncbi.nlm.nih.gov/datasets/genome/GCA_002759435.3/
    - Used in: BRC-Analytics platform and this study

12. **NCBI SRA and BioProject**
    - Santana et al. BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA904261
    - Wang et al. BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1086003

## Literature Survey Methodology

13. **Comprehensive *C. auris* RNA-seq Survey**
    - Location: `/home/anton/git/claude-projects/rnaseq/Cauris_rna_seq_survey/`
    - Combined survey document: `combined/COMBINED_LITERATURE_SURVEY.md`
    - Statistics: 32 unique papers (2018-2025), three independent search strategies
    - Visualizations: `combined/combined_overview.png`, `combined_analysis.png`, `combined_statistics.png`

14. **Finding *C. auris* in Metagenomic Repositories**
    - Title: "Finding Candida auris in public metagenomic repositories"
    - URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10798454/
    - Content: Screening ~300,000 SRA metagenomic runs for *C. auris* (2010-2022)

## Genome Sequencing and Phylogenomics

15. **Benchmark Genome Dataset**
    - Title: "*Candida auris* Whole-Genome Sequence Benchmark Dataset for Phylogenomic Pipelines"
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/33809682/
    - PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC8002225/
    - Content: 23 *C. auris* genomes for validating genomic analyses

16. **Complete Genome Assemblies**
    - Title: "Complete genome assembly of Candida auris representative strains of three geographical clades"
    - Journal: *Microbiology Resource Announcements*
    - URL: https://journals.asm.org/doi/10.1128/mra.00882-23
    - Strains: B11103 (Clade I), B11221 (Clade III), B11244 (Clade IV)

17. **Fifth Clade Discovery**
    - Title: "Confirmation of fifth Candida auris clade by whole genome sequencing"
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/36154919/
    - PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC9586689/

## Additional High-Impact Publications (from Survey)

18. **Nature Microbiology - Host Immune Response (2020)**
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/32839538/
    - GEO: GSE154911
    - Content: QuantSeq 3' mRNA-seq of host PBMC response to *C. auris*

19. **Nature Microbiology - LncRNA DINOR (2021)**
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/34083769/
    - GEO: GSE171261
    - Content: First functional lncRNA in *C. auris* as virulence factor

20. **Nature Communications - Multidrug Resistance (2018)**
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/30559369/
    - BioProject: PRJNA445471
    - Content: Multidrug resistance mechanisms across four clades

21. **PLOS Pathogens - Single-cell RNA-seq (2024)**
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/38745637/
    - Content: First scRNA-seq study in *C. auris*, IL-1R immune evasion

22. **Cell Reports - White-Brown Switching (2025)**
    - PubMed: https://pubmed.ncbi.nlm.nih.gov/37925028/
    - Content: Phenotypic switching mechanisms

## Galaxy Platform

23. **Galaxy Main**
    - URL: https://usegalaxy.org
    - Santana history: https://usegalaxy.org/u/cartman/h/prjna904261-final
    - Wang history: [User to provide if public]

24. **BRC-Analytics Platform**
    - URL: https://brc-analytics.org
    - Description: Standardized bioinformatics platform for pathogen genomics

## Software and Tools

25. **DESeq2**
    - Version: 2.11.40.8+galaxy0
    - Purpose: Differential expression analysis
    - Galaxy tool: toolshed.g2.bx.psu.edu/repos/iuc/deseq2

26. **STAR Aligner**
    - Purpose: RNA-seq alignment
    - Usage: 31.2% of surveyed *C. auris* studies

27. **HISAT2**
    - Purpose: RNA-seq alignment
    - Usage: 62.5% of surveyed *C. auris* studies (dominant aligner)

28. **HTSeq / featureCounts**
    - Purpose: Gene quantification
    - Usage: HTSeq 37.5%, featureCounts 12.5%

29. **FastQC**
    - Purpose: Quality assessment
    - Usage: 73% of surveyed studies

## Analysis Scripts and Repositories

30. **Local Analysis Repositories**
    - Survey repo: `/home/anton/git/claude-projects/rnaseq/Cauris_rna_seq_survey/`
    - Santana analysis: `/home/anton/git/claude-projects/rnaseq/santana24_PRJNA904261/analysis/`
    - Wang analysis: `/home/anton/git/claude-projects/rnaseq/wang24_PRJNA1086003/analysis/`
    - Scripts: `analyze_combined_data.py`, `visualize_combined.py`, gene mapping tools

---

## Summary Statistics from Literature Survey

- **Total unique papers**: 32
- **Date range**: 2018-2025
- **Peak year**: 2021 (11 papers, 34.4%)
- **B8441 genome usage**: 75% of studies
- **Tool consensus**: HISAT2 (62.5%), DESeq2 (68.8%), HTSeq (37.5%)
- **Research focus**: Drug resistance (34.4%), Stress response (18.8%), Biofilm (12.5%)
- **Search strategy finding**: Claude + ChatGPT had 0% overlap despite same databases/date

---

*Last updated: December 3, 2025*
